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I. INTRODUCTION 
The calcium ion is of vital importance to various physiologie sys­
tems. For example, the neural, neural effector, musculo-skeletal, and 
endocrine systems are dependent upon the presence of calcium to perform 
their function adequately. Recently, vitro studies utilizing the 
perfused rat pancreas have established a calcium requirement for the 
secretion of insulin (Grodsky et al., 1956). 
The study of insulin secretion has been greatly enhanced during the 
past decade by the development of the radioimmunoassay for insulin deter­
mination (Yalow and Berson, 1960). These techniques have made the pre­
cise quantitative determination of insulin possible. Intensive studies 
to elucidate the basic processes regulating insulin secretion have 
paralleled the development of these radioimmunoassay techniques. 
Mathematical models have been proposed to study and evaluate the 
interrelationship of factors which govern insulin secretion and glucose 
utilization. The use of these models has been proposed for clinical 
evaluation of diabetic subjects (Ackerman e;t al., 1964; Cerasi, 1967). 
In this study the influence of calcium ion on insulin secretion in 
vivo has been investigated. The radioimmunoassay was utilized for insulin 
determinations. The objectives of this investigation were: (1) to study 
the dynamic response of glucose-induced insulin secretion during spontane­
ous and induced hypocalcemic states, and (2) to establish the regulatory 
coefficients of a mathematical model which depicts the interrelationship 
^between insulin secretion and glucose utilization associated with hypo­
calcemic and normocalcemic states. 
lb 
The initial phase of this study consisted primarily of several 
months effort to achieve satisfactory precision with the radioimmuno­
assay for insulin. Thereafter, the study of insulin secretion associated 
with hypocalcemia was divided into two phases: (1) spontaneous hypo­
calcemia (postparturient paresis) in the dairy cow, and (2) induced 
hypocalcemia in the pig. 
The experiments conducted in dairy cows were initiated as a joint 
project with Dr. E. Travis Littledike and Dr. Shannon C. Whipp of 
this laboratory, because of the geographical distribution of the dairy 
cows available, the urgency of treatment in postparturient paresis, and 
the demand for technical assistance during the experiments. 
The physiologic data supplied by the ^  vivo studies in pigs were 
used as a basis for determination of the regulatory coefficients in the 
mathematical model. 
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II. REVIEW OF LITERATURE 
A. Chemistry of Insulin 
From the time of the first biological demonstration of the hypo­
glycemic effect of pancreatic islet cell extract by Banting and Best 
(1921) extensive research has only partially clarified the chemical, 
physiologic and pharmacologic properties of insulin (Banting and Best, 
1922). 
Some major contributions toward understanding the chemical proper­
ties of insulin include its crystallization (Abel et al., 1927), deter­
mination of its amino acid sequence and structure (Sanger, 1956, 1960), 
and the complete synthesis of sheep and human insulin (Katsoyannis, 1966). 
Physicochemical techniques used for characterization of the insulin mole­
cule are being used in the study of other polypeptide hormones. 
The use of homologous and heterologous insulin, as well as insulin 
analogs, has provided the basis for determination of many biologic and 
immunologic properties of insulin. The advent of the radioimmunoassay 
(Yalow and Berson, 1960) for insulin determination has emerged as the 
primary procedure which made the detailed study of insulin secretion 
possible. 
1. Variations in amino acid sequence 
The insulin monomer of most mammalian species consists of a 21-amino 
acid A chain (acidic) and a 30-amino acid B chain (basic). Two interchain 
disulfide bonds connect the A and B chains; in addition an intradisulfide 
bond connects cysteines at positions 6 and 11 on the A chain (Sanger, 1956, 
1960). Insulins from cattle, sheep and horse differ from each other at 
amino acid positions 8, 9, and 10 between the intradisulfide bridge. These 
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three positions are identical in pig, rabbit, whale and human insulin 
(Sanger, 1960). The structure of human insulin is similar to that of 
porcine insulin, the exception being amino acid 30 of the B chain where 
threonine (human) is substituted for alanine (Nicol and Smith, 1950). 
While the insulins of most mammalian species studied differ by only 
a few amino acids in selected positions, guinea pig insulin is an excep­
tion; 17 amino acid sequence differences exist between guinea pig and 
porcine insulin. This number is greater than that found for chicken 
insulin and is comparable to the differences that can be assumed from 
the partial sequences of various fish insulins which have been deter­
mined (Smith, 1955). Insulin may also exist in more than one molecular 
form within a single species. When the amino acid sequence of rat insu­
lin was investigated, two types of molecules were found which contained 
one and two residues of lysine, respectively; the two types were present 
in nearly equal amounts (Smith, 1964). In later studies it was found in 
one type that lysine at 629 had been replaced by methionine (Smith, 1965). 
2. Effect of physicochemical relationships on hormonal activity 
The "locus" of hormonal activity in insulin has been studied by con­
trolled physicochemical alterations of the insulin molecule and the use 
of homologous and heterologous insulin. Despite the many ingenious 
approaches to this study, its "locus" of biologic activity has not been 
entirely defined. 
The disulfide bridges must remain intact for biologic activity; when 
broken by reduction (Stem and White, 1937) there is immediate inactiva-
tion of biologic activity (Sanger, 1960). In contrast, it has been shown 
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that blockage of free amino groups, by acetylation, causes no change in 
biologic activity (Stem and White, 1938). Other investigators have 
compared the biologic activity of the individual A and B chains of beef 
insulin. The isolated A chain has a weak stimulatory effect (about 
1/1000 that of insulin) on glucose uptake by rat diaphragm, while the B 
chain appears to be quite inert (Surmaczynska and Metz, 1969). Correla­
tion of biologic activity with loss of terminal carboxyl groups has been 
demonstrated. Exposure of insulin to carboxypeptidase caused diminished 
biologic activity of 50 percent. It was concluded that the alanine (C 
terminal) of the B chain of the insulin molecule is not essential for 
its biologic activity; it appeared, however, that loss of terminal 
asparagine (A chain) leads to a decrease of activity (Harris and Li, 1952). 
This was also confirmed by Nicol (1960) and Arquilla et al. (1969). Re­
moval of eight amino acids from the C terminal end (B chain), by trypsin, 
however, resulted in 85 percent or greater loss of biologic activity of 
the intact insulin molecule (Nicol, 1960; Arquilla et al., 1969). 
Fluorescent derivatives of insulin have been prepared by reacting 
crystalline insulin with fluorescein isothiocyanate. The biologic activity 
of these derivatives, as estimated by the hypoglycemic response in fasted 
rabbits, was approximately 60 to 80 percent (30-minute point) that of the 
native hormone (Tietze e^ , 1962). In yet another study the mono-
conjugated fluorescent insulin, diconjugated fluorescent insulin, and the 
triconjugated insulin assayed approximately 40 percent, 4 percent, and 
no measurable biologic activity, respectively. The insulin derivative 
with the least distortion of its antigenic determinants (monoconjugated 
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fluorescent insulin) had more biologic activity than the other deriva­
tives (Arquilla ejù al., 1969). 
lodination of the insulin molecule also reduced its biologic 
activity and was related directly to the number of iodine atoms per 
insulin molecule. The incorporation of more than one atom of iodine per 
molecule of insulin (assumed molecular weight 6,000) resulted in a pro­
gressive loss of biologic activity. However, increasing iodination of 
insulin had little, if any, effect on the immunologic properties inves­
tigated (Izzo ^ ^-5 1964). The average incorporation of total iodine 
should not exceed one atom per molecule of insulin if the labeled insu­
lin is to be used for physiologic studies. These recommendations are 
based on the mouse convulsion test, rat epididymal fat pad test and the 
isolated rat diaphragm test (Izzo et al., 1964). 
Since the advent of insulin treatment of the diabetic subject, the 
phenomena of insulin "resistance" has presented a rather serious problem 
in several patients. The use of homologous and heterologous insulin in 
several recipient species has led to many interesting observations of 
insulin resistance. However, the underlying factors of insulin resis­
tance remain obscure. Research has been directed toward an immunologie-
biologie antagonism to ejqjlain insulin "resistance." The conparative 
usefulness of crystalline human, porcine, dealaninated porcine, and 
bovine insulin for treatment of insulin resistance has been studied. 
Some patients were found to be more sensitive to either human, porcine, 
or dealaninated porcine insulin than to bovine insulin. Degrees of 
resistance could not be correlated with vitro insulin binding capa­
city of sera from responsive patients (Boshell et al., 1964). 
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The injection of both homologous and heterologous insulins into 
cows (Renold et al., 1966; LeCompte et al., 1966) and rabbits (Grodsky 
£t a^. 5 1966) has resulted in the production of antibodies, islet histo­
pathologic changes, and varying degrees of insulin resistance and carbo­
hydrate intolerance. These findings indicate that either a difference 
exists between the state of pancreatic and circulating insulin or that 
alterations in physicochemical structure of insulin due to extraction 
have rendered it immunogenic. 
An immunologic response to crystalline insulin in adjuvant, adminis­
tered over several months, was elicited in the bovine species. The 
immunogenic response occurred within 2 to 4 weeks with heterologous in­
sulin but required a longer period of time for homologous insulin. The 
homologous insulin, of course, represents extracted and crystallized 
pancreatic insulin; perhaps these procedures altered its structure in a 
manner that produced antigenicity. In addition, any protein, however 
pure, may contain traces of contaminating closely related proteins that 
may be immunologically active and undetectable by available physical and 
chemical techniques. The normal glucose tolerance found in these cattle 
shows that immunologic response is not necessarily indicative of altered 
carbohydrate metabolism (Renold et al., 1966). 
3. Types of "circulating insulin" 
Following the advent of a radioimmunoassay for insulin, it was soon 
realized that the quantitative data supplied by bioassay and immunoassay 
on identical samples were not comparable in many cases. This realization 
motivated rather intensive investigation to account for these discrepencies. 
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Studies using bioassays have shown the presence of different forms 
of insulin-like activity (ILA) in plasma which can be separated by 
various techniques, such as addition of insulin antibody (anti-insulin) 
to plasma, extraction with acid ethanol, treatment of plasma with cation 
exchange resin, and electrophoresis (Lyngs^e, 1967). However, these 
methods have not succeeded in separating different forms of insulin 
activity from insulin which can be determined by the immunoassay of Yalow 
and Berson (1960), i.e. immunoreactive insulin (IRI). Therefore, it 
has been maintained that the different forms of ILA found in plasma do 
not represent different forms of plasma insulin, but other plasma fac­
tors with ILA (Lyngs^e, 1967). 
Earlier studies (Antoniades and Gundersen, 1961; Antoniades et al., 
1961, 1965) of blood extracts and whole serum suggested that the demon­
strable ILA (rat diaphragm assay) was the "free" portion of insulin. 
The "bound" insulin was demonstrated after release by adipose tissue 
extracts or treatment at pH 10. The "free" form of insulin corresponded 
in its physicochemical, immunologic, and biologic properties to crystal­
line insulin. The "bound" form of insulin exhibited a higher molecular 
weight, slower electrophoretic mobility and diminished reactivity with 
insulin antisera; however, the antisera inhibited the biologic activity 
of acid ethanol extracts of bound insulin on isolated epididymal adipose 
tissue (Antoniades e^ al., 1965). Other investigators suggest that adi­
pose tissue extracts do not free or release insulin from a complexed 
form, but alter some serum constituent(s) which potentiates the biologic 
effectiveness of a given amount of hormone; since IRI did not increase 
f 
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although biologie activity was enhanced by adipose tissue extracts (Kip-
nis and Stein, 1954). 
That part of pancreatic extractable or pancreatic venous serum ILA 
which is completely inhibited by insulin antisera has been referred to 
~ as the "typical" form of insulin (Katzen and Glitzer, 1968) and has also 
been designated suppressible insulin-like activity (SILA). This corres­
ponds to the IRI measured by the radioimmunoassay of Yalow and Berson. 
The ILA of pancreatic extract which is not suppressed by insulin anti-
sera (rat epididymal fat pad assay) has been designated "atypical" in­
sulin (Slater ejt al., 1961) ; also referred to as non-suppressible insulin­
like activity (NSILA). Considerable evidence thus exists for different 
forms of ILA in plasma; however, these forms have not been completely 
defined as to source or biologic importance (Samaan et al., 1963; Berson 
and Yalow, 1965; Gorden and Roth, 1968; Roth et al., 1968). It has been 
suggested that ILA in gamma-beta globulin preparations, the major portion 
of total serum insulin activity described in acid-ethanol extracts of 
serum, "bound" insulin, atypical insulin, and NSILA bioassayed in diluted 
serum are all one and the same substance (Poffenbarger et al., 1968). 
Plasma insulin, as measured by radioimmunoassay, appears to be com­
posed of at least two components — a major component "little" insulin 
which is indistinguishable from the major component of pancreatic insulin, 
and a second component "big" insulin. Both components react to some 
degree with insulin antisera and are secreted by the pancreas in re­
sponse to appropriate stimuli (Gorden and Roth, 1969). 
"Little" insulin cross-reacts with purified porcine insulin in the 
immunoassay. However, "big" insulin has an immunoreactivity that is 
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clearly nonidentical with porcine insulin (Roth et al., 1968). Thus, 
only a fraction of the "big" insulin may be detected by immunoassay. It 
is believed that "big" insulin contains a major portion of the insulin 
structure intact within it because of immunologic reactivity. These 
two components, "little" and "big" insulin, were obtained from plasma 
when filtered on Sephadex G-50. One peak, quite discrete, appeared at 
0.45 of the distance between the protein and salt peaks ("little" in­
sulin). The other peak ("big" insulin) was detected approximately half­
way between "little" insulin and the plasma protein peak. When highly 
purified crystalline porcine insulin (pancreatic insulin) was added to 
insulin-free plasma, only a single peak was observed which corresponded 
to "little" insulin. The approximate molecular weight of "little" in­
sulin and "big" insulin was determined as 5,000 to 6,000 and 8,000 to 
9,000, respectively (Roth e^ a^. , 1968). 
Other investigators have demonstrated by gel filtration a fraction 
having ILA and referred to as peak "b" (Steiner and Oyer, 1967). The 
next important consideration is whether "big" insulin is analogous or 
identical to the major component of peak "b". The major component of 
peak "b" which probably has a biologic activity about 2 to 5 percent 
that of insulin and exhibits immunologic reactivity (which varies from 
antiserum to antiserum) of about 40 to 100 percent of insulin is now re­
ferred to as proinsulin (Steiner et al., 1968; Gorden and Roth, 1969). 
It is believed that "big" insulin is probably proinsulin since treatment 
with low concentrations of trypsin will alter the elution pattern of 
"big" insulin in a manner analogous to the changes observed on trypsin 
treatment of proinsulin (Gorden and Roth, 1969). 
Porcine proinsulin itself does not affect glucose metabolism of 
adipose tissue or hemidiaphragm of the normal rat (Shaw and Chance, 1968). 
Proinsulin exerts a biologic effect after it is converted by an enzyme 
or group of enzymes present in adipose tissue and diaphragm muscle, to 
a molecule which is similar to or identical with insulin (Shaw and 
Chance, 1968; Steiner et al., 1968). In another study, with the forearm 
as an experimental model, the major effect of proinsulin was on the adi­
pose tissue while insulin affected muscle primarily (Finberg and Merimee, 
1970). Proinsulin (porcine and bovine) has now been isolated and par­
tially characterized (Shaw and Chance, 1968; Chance and Ellis, 1968; 
Steiner et ^ ., 1968). The amino acid sequence of porcine proinsulin 
has been determined and found to contain 84 amino acids. The 21-
amino acid sequence of the A chain and the 30-amino acid sequence of 
the B chain are connected by a 33-amino acid peptide which joins the 
terminal-free carboxyl group of alanine (B chain) with the terminal-
free amino group of glycine (A chain). The calculated molecular weight 
was 9,082, on the basis of its amino acid determination. 
The secretion of "little" insulin and "big" insulin in response to 
a glucose stimulus has been studied. Following the oral administration 
of glucose to normal adults total plasma insulin rises promptly, reaches 
a peak at about 30 minutes, and gradually returns to normal in the next 
hour or two. Early after the administration of glucose nearly all of 
the plasma insulin is "little" insulin, whereas by 2 hours a definite 
fraction of plasma insulin is in the form of "big" insulin. "Big" 
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insulin ranged from 0 to 5 percent within 15 minutes (oral glucose 
tolerance test, 100 gm glucose), whereas at 2 hours, "big" insulin 
ranged from 5 to 28 percent (Gorden and Roth, 1969). 
4. Radioimmunoassay of insulin 
The principles of radioimmunoassay are readily summarized in the 
set of competing reactions: 
H* + Ab H"-Ab 
(Free labeled hormone) Specific (Bound labeled hormone) 
"F" antibody "B" 
+ 
H (unlabeled hormone in plasma 
^ or standards) 
H-Ab 
Labeled hormone binds to specific antibody to form a labeled antigen-anti­
body complex. Radioimmunoassay depends on the ability of unlabeled hor­
mone in plasma or other solutions to compete with labeled hormone for 
antibody and thereby to inhibit the binding of labeled hormone. As a 
result of competitive binding, the ratio of antibody-bound (B) to free 
(F) labeled hormone, denoted B/F, is diminished as the concentration of 
unlabeled hormone is increased. The concentration in an unknown sample 
can be obtained by comparing the inhibition observed (B/F ratio) with 
that produced by standard solutions containing known amounts of hormone 
(Berson and Yalow, 1968). The radioimmunoassay for some 18 peptide hor­
mones has been described since the first use of this principle for the 
assay of plasma insulin (Berson and Yalow, 1968). 
The essential materials for radioimmunoassay include the unlabeled 
antigen, the labeled antigen, the specific antibody, and some technique 
for separating the antibody-bound and free-labeled hormone. Several 
procedures have been described for separating the bound insulin from 
free insulin (Grodsky and For sham, 1960; Hales cind Ran die, 1963; Morgan 
et al., 1964; Yalow and Berson. 1960). The double antibody principle 
for this separation is quite successful and in general use. 
The double antibody system used in this study was composed of an 
anti-insulin antibody and an anti-"anti-insulin antibody," similar to 
that described by Hales and Randie (1963). For example, the antibody 
against porcine insulin is formed in the guinea pig, and the serum is 
collected. The guinea pig serum containing the anti-insulin antibody 
serves as the antigen for production of the second antibody (anti-anti-
insulin antibody) in the rabbit. When these two antibodies are reacted, 
they combine to form a filterable insoluble complex which serves as the 
binding agent for insulin in the immunoassay. The proportion of the 
labeled insulin which is bound to the binding agent will depend on the 
amount of unlabeled insulin previously exposed to the binding sites. 
Final separation of the bound-labeled and free-labeled insulin is accom­
plished by using an appropriate filter and buffer to wash the free-
labeled insulin from the sample. 
The radioimmunoassay's importance is based on its specificity and 
sensitivity which permits accurate measurements 10"^ to 10"^^ gm/ml of 
insulin. The specificity of the immunoassay is dependent basically on 
specificity of the antibody employed. In turn, the desired antibody 
13 
specificity is primarily dependent on antigen purity. Difficulties in 
the preparation of a highly purified stable peptide hormone have slowed 
the development of the radioimmunoassay for many peptide hormones. In­
sulin, however, is a remarkably stable protein which is very resistant 
to denaturing agents. It retains immunologic reactivity despite treat­
ment with chemicals like trichloroacetic acid (Taylor a^., 1958). 
Most peptide hormones contain at least one tyrosine residue which 
can be labeled with a radioisotope of iodine. Furthermore, it may be 
possible to conjugate a tyrosine-containing peptide with those peptide 
hormones or fragments lacking a tyrosine residue. Radioiodine is usually 
selected to label peptide hormones because it provides higher specific 
activity than the isotopes of carbon or tritium (Berson and Yalow, 1968; 
Izzo et al., 1964-; Glover et al., 1967). When 16 equivalents of iodine 
monochloride are reacted with one equivalent of insulin, 11.1 atoms of 
iodine are stably attached to insulin (mol. wt. 6000). If positions 3 
and 5 of the four tyrosyl residues of insulin were the only reactive 
sites, the maximum number of iodine atoms that could be substituted 
would be 8. Hence, it seems reasonable to assume that under appropriate 
conditions there are other groups that bind iodine in a stable fashion 
(Izzo et al., 1964). 
The radioimmunoassay for insulin has now been extended to include 
pro insulin and other fractions of insulin ( Surmaczynska et al., 1969; 
Shaw and Chance, 1968; Gorden and Roth, 1969; Steiner et al., 1968). 
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B. Secretion of Insulin 
It is now known that a great variety of substances or stimuli affect 
insulin secretion. As the number of known factors which influence in­
sulin secretion has increased, the complexity of this physiologic event 
has become increasingly difficult to understand. Thus, it is perhaps 
surprising that a unifying concept to explain insulin secretion, at 
least in part, has emerged. This concept involves various hormones 
(factors) which act through adenyl cyclase and cyclic 3's5' adenosine 
monophosphate (cAMP) to control insulin secretion. The adenyl cyclase 
system has been shown to be dependent on certain cations. 
1. Morphologic details of 3-cell secretion 
The islands of Langerhans comprise approximately 1 to 2 percent of 
the pancreatic volume. The 3-cells, in turn, comprise 60 to 70 percent 
of the islet cell population. The 3-cell is surrounded by a continuous 
plasma membrane and contains the following organelles within the cyto­
plasm: ergastoplasm, mitochondria, secretory granules, Golgi complex, 
and a nucleus. The $-granules are enclosed within smooth meirbranous 
sacs and are scattered throughout the cytoplasm (Lacy, 1967). 
The capillaries within the islets are lined by endothelial cells 
that contain mitochondria, ergastoplasm and a small Golgi complex ad­
jacent to their nuclei, whereas the peripheral extensions of the endo­
thelial cytoplasm are thinner and devoid of these organelles. Fenestras 
are present in the thin peripheral cytoplasmic layer and are bridged by 
a thin line, which appears to be continuous with the plasma membrane of 
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the endothelial cell. These foci probably represent areas for rapid 
transport of material between the blood stream and the extravascular 
space (Lacy, 1967). 
The ultrastructural changes which occur in the 3-cells of the rat 
pancreas have been studied after applying various types of stimuli (Lacy, 
1959, 1961; Williamson et , 1961). A comparison of the sequential 
changes in the organelles of the B-cell under these conditions has made 
it possible to describe the mechanism of formation, storage and release 
of 3-granules. 
The formation of 3-granules apparently occurs within the ergasto-
plasm. The ergastoplasm is transformed into ergastoplasmic sacs, the 
amorphous substances within the sacs apparently being a precursor of 
insulin (biologically inactive). Mature, distinct 3-granules are formed 
from the amorphous material within the ergastoplasmic sacs (Lacy, 1967). 
When the cell is stimulated to release insulin, the 3-granules move to 
the cell surface, and the sacs encasing the granules fuse with the 
plasma membrane. The presence of rnicrotiibules within the 3-cell has 
been suggested by electron microscopy studies. In a few cases a fila­
mentous structure was observed linking the sac around a 3-granule to 
the plasma membrane (Lacy, 1968). The membranous sac fuses with the cell 
membrane and ruptures, and the granule is released into the extracellular 
space where it undergoes rapid dissolution. After the 3-granules have 
been liberated into the extracellular space, they are no longer visible 
by electron microscopy (Lacy, 1967). The insulin is apparently in solu­
tion in the extracellular fluid where it must traverse the basement mem­
branes and the endothelium before entry into the capillary. 
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Insulin may also be present in an agranular form. Under conditions 
of prolonged stimulation of the pancreas» degranulated $-cells can still 
produce and secrete insulin at a rapid rate (Lazarus and Volk, 1962). 
Insulin has also been detected in the fetal pancreas before granule 
formation (Grillo, 1964; Milner, 1969; Willes ^  , 1969). Insulin 
production has been noted in 3-cell tumors without B-granule formation 
(Steiner and Cunningham, 1967). Organ cultures of the fetal pancreas 
are now possible and have enhanced the study of insulin secretion 
(Lambert et al., 1969). In addition, pancreatic allograft has recently 
been utilized to study the endocrine function of the pancreas (Ota 
et al., 1968). 
2. Hormonal influences on insulin secretion 
A review of hormones which apparently influence insulin secretion 
reveals a potential for finer gradation of regulation than perhaps ex­
pected; regulation being related to changing physiologic states. For 
many years the enteric hormones have been recognized as important in the 
regulation of exocrine pancreatic secretions. The possibility that 
these enteric hormones may also play a role in controlling the endocrine 
secretions of the pancreas was suggested by the demonstration that an 
oral glucose load was disposed of more rapidly than an intravenous load 
(Mclntyre et al., 1964) and that a greater rise in circulating insulin 
was associated with oral glucose administration (Di^re, 1964; Elrick 
et al., 1964). Evidence was soon presented that the augmentation of 
insulin secretion was due to the release of a hormone from the intes­
tinal wall (Mclntyre et al., 1965). 
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Intravenous infusions of purified secretin administered to healthy 
men induced a rise in the fasting level of plasma IRI and augmented the 
IRI response to intravenous glucose. In addition, it appeared that the 
effect of combined secretin and glucose was greater on insulin secre­
tion than the sum of secretin and glucose given independently (Boyns 
et , 1967). 
In contrast with the effect of exogenous secretin, endogenous secre­
tin, stimulated by intraduodenal installation of citric acid, did not 
augment the plasma IRI levels achieved during intravenous glucose in­
fusion (Boyns et al., 1967). It was suggested that secretin, though 
insulinotropic, is only so in non-physiologic amounts. However, in 
another study the intravenous infusion of pancreozymin caused a marked 
increase of IRI and iramunoreactive glucagon (IRG) in the pancreatic 
venous blood of dogs and a rise in the plasma glucose (Buchanan ^  al., 
1968). Perhaps the rise in IRG stimulated insulin secretion in this 
case and was not a direct effect of pancreozymin. Still further investi­
gations have shown that secretin, pancreozymin and gastrin cause a 
striking increase in insulin concentrations in the pancreaticoduodenal 
venous plasma after their rapid endoportal injection in anesthetized 
dogs (Unger e^ , 1967). Human synthetic gastrin I has been tested 
in the isolated mouse pancreas. Low concentrations of gastrin inhibited, 
while higher concentrations of gastrin enhanced insulin secretion in the 
presence of glucose (Lemmark ei^ , 1969). The demonstration that these 
three hormones possess insulin-releasing activity suggests that there is 
in the gastrointestinal tract a chain of ^ -cytotropic hormones (pancreozy­
min, secretin, and gastrin) from antrum to ileum that is capable of 
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augmenting insulin secretion as required for disposal of substrate loads. 
It is suggested that the existence of this "entero-insular axis" pre­
vents high substrate concentrations that would otherwise follow ingestion 
of large meals if the insular response were entirely a function of 
arterial substrate concentrations (Unger et al., 1967). 
The first observations that glucagon secretion is associated with, 
or followed by, insulin release (Foa et al., 1952) has been studied 
further (Samols et al., 1966). A rise in arterial blood glucose con­
centration has, however, been looked upon as an essential intermediate 
step (Foa e^ , 1952); the stimulatory effect of glucagon upon insulin 
secretion being a secondary phenomenon. The rapid, intravenous injec­
tion of glucagon into healthy normal subjects produced a striking rise 
in IRI within one minute and before any change in arterial glucose con­
centration occurred. Plasma IRI levels reached their peak within 10 
minutes and began to fall thereafter. In contrast blood glucose levels 
were highest 20 to 30 minutes after the injection. A second glucagon 
injection during the hyperglycemic phase produced a larger rise in plasma 
insulin than the first (Samols e^ , 1966). 
A direct effect of glucagon upon the 6-cells of the pancreas is the 
most likely explanation of the increase in insulin secretion (Samols 
ej^ , 1966). In the liver cell glucagon activates cAMP (Sutherland 
and Rail, 1960) which in turn activates phosphorylase and thereby in­
creases glycogenolysis. It was postulated that a similar process occurs 
within the B-cell and may explain insulinogenic properties of glucagon. 
Sutherland and Rail (1960) based this postulate in part on the following 
criteria: 
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(1) It was consistent with the known biochemical properties of 
glucagon. 
(2) Pancreatic 0-cells contain glycogen in moderate to large 
amounts. The insulinogenic effect of glucagon is greatly enhanced by 
conditions which favor glycogen deposition, e.g. prior feeding or hyper­
glycemia, and is reduced or abolished by conditions which reduce tissue 
glycogen stores, e.g. starvation. 
(3) Plasma insulin levels fall during constant glucagon infusions, 
suggesting exhaustion of 6-cell glycogen stores or of 3-cell insulin 
stores- Raising the blood glucose level by glucose infusion increases 
intra-3-cell glycogen deposits and restores the insulinogenic response 
to glucagon (Samols et al., 1966). Thus, the insulinogenic role of 
glucagon becomes one example which links the adenyl cyclase system to 
insulin secretion. 
Adrenocorticotropic hormone (ACTH) has also been shown to stimulate 
the release of insulin from the pancreas. This action has been documented 
in studies with mice and rats (Genuth and Lebovitz, 1965; Love et al., 
1965). In the mouse, ACTH causes a rise in plasma insulin that is maxi­
mal 10 minutes after intravenous administration. As little as 5 iJg of 
ACTH i.V. caused a greater rise in plasma insulin than was obtained 
with 25 mg of glucose given intravenously. ACTH stimulated insulin se­
cretion two-fold over controls when mouse pancreases were incubated in 
an appropriate medium (Genuth and Lebovitz, 1965). 
The chronic administration of growth hormone (GH) results in the pro­
duction of hyperglycemia and antagonism to insulin action (Young, 1951). 
20 
In contrast, rather than hypt:glycemia, the immediate response to a 
single injection of GH is a prompt hypoglycemia (Milman and Russell, 
1950). Recent investigari.as have shown that bovine growth hormone (BGH) 
when injected into rats resulted in a diminished rate of insulin degrada­
tion, thereby enhancing its biologic activity (Mahler and Szabo, 1959). 
Epinephrine induces a hyperglycemic state while concomitantly in­
hibiting insulin secretion. Initially this effect was attributed to a 
disturbance of pancreatic circulation (Anderson and Long, 1947). The 
role of diminished pancreatic circulation, which contributes to sup­
pression of insulin secretion, has been supported by studies with 
angiotensin II in man (Mintz e^ , 1957). However, it was found later 
that epinephrine inhibits insulin secretion, independent of its circu­
lation (CooTe and Randle, 1964). This inhibitory effect (pieces of rat 
pancreas) appears to be mediated through a-receptors since it is blocked 
by a-adrenergic blocking agents and only slightly affected by ^-adrenergic 
blocking agents (Malaisse et al., 1957b). 
The role of the ^-adrenergic receptor may be more influential than 
expected, although masked by the epinephrine a-adrenergic effect. In 
the presence of a-adrenergic blockade, epinephrine may actually stimu­
late insulin release and this effect can be blocked by B-adrenergic 
blocking agents (Porte, 1957). Since the a-receptors seem to predomi­
nate in the pancreas, it would appear that the normal physiologic func­
tion of sympathetic stimulation via the adrenal medulla is to inhibit 
insulin release (Butcher ejk al., 1958). The inhibitory effect of 
epinephrine on insulin has been verified by other ^  vitro and 
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tests (Kris al., 1966; Nelson et^ a^., 1967; Porte et al., 1966; Porte, 
1967). The impairment of insulin secretion in patients with pheochromo-
cytoma can be reversed by a-adrenergic blocking agents or removal of the 
tumor (Vance et al., 1969). 
Several other factors have been shown to inhibit insulin secretion. 
Acute hypoxia inhibits insulin secretion and may be mediated through the 
increase of catecholamines (Eaum and Porte, 1969). The inhibition of 
insulin secretion by insulin has been observed in isolated hamster pan­
creatic islets; the degree of inhibition being increased as the glu­
cose concentration was elevated (Sodoyez et al., 1969). 
3. Adenyl cyclase system and insulin secretion 
The hyperglycemic response to epinephrine represents one of the best 
understood actions of catecholamines (Sutherland and Robinson, 1966). 
Experiments designed to elucidate the mechanism of this effect led even­
tually to the discovery of cAMP (Rail and Sutherland, 1959; Sutherland 
and Rail, 1960). It has been shown that the activity of epinephrine, 
glucagon and ACTH are mediated in part through cAMP (Rail and Sutherland, 
1959; Sutherland and Rail, 1960; Haynes el^ al., 1960; Grahame-Smith 
et 1957). 
The hypothesis has been developed that many hormones act by way of 
a two messenger system. Such hormones may be regarded as first messengers 
which travel from their cells of origin to the cells of their target 
tissues to stimulate the formation therein of a second messenger. The 
only second messenger identified to date is cAMP, although it seems 
22 
probable that other second messengers will eventually be discovered. 
Within this framework, the adenyl cyclase system functions both as a 
discriminator for environmental signals and as a signal generator 
(Robinson et al., 1968). 
The inhibitory effect by epinephrine on glucose stimulated insulin 
release led to the view that the adenyl cyclase system may play a role 
in the control of insulin secretion (Coore and Handle, 1964). It was 
further postulated that the inhibitory effects of catecholamines are 
mediated through activation of a-adrenergic receptors; «-adrenergic 
blocking agents abolish the inhibitory effect while being slightly 
affected by B-adrenergic blocking agents (Malaisse et al., 1967a). Iso-
protemol, a predominantly c—adrenergic agent, when mixed with an a-
adrenergic blocking agent (phenoxybenzamine), stimulated insulin secre­
tion from pieces of rat pancreas in vitro. Theophylline, caffeine, cAMP, 
glucagon, ACTH, and thyrotropin, all of which are believed to act through 
the adenyl cyclase systems in the liver and adipose tissue, also poten­
tiated insulin secretion maximally at high levels of glucose (300 mg/ 
100 ml), i.e. greater insulin secretion than with the high glucose con­
centration alone. In all cases, stimulation of insulin secretion could 
not be detected when glucose was absent or in low concentrations (less 
than 100 mg/100 ml) (Malaisse e^t , 1967a). Similar results have been 
observed using intact mice (Bressler et al., 1969). 
When epinephrine was infused into adrenalectomized rats, the injec­
tion of theophylline (a potent 3-receptor agonist) caused an 8-fold in­
crease in plasma insulin. This effect of theophylline was augmented 
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(30- to 40-fold increase) by pretreatment with an a-adrenergic blocking 
agent (phentolamine ), and was completely blocked by ^-adrenergic blockade 
(propranolol) (Turtle et al., 1967). The effect of a-receptor stimula­
tion might be mediated by a decrease in the level of cAMP, while 3-
receptor effects could be mediated by an increase in cAMP (Robinson 
et al., 1967; Porte, 1967). The view that all 6-receptor effects are 
mediated by cAMP is well supported; however, the a-receptor component of 
this hypothesis is more controversial. Hormones such as glucagon and 
epinephrine are believed to stimulate adenyl cyclase activity in the 
cell membrane and cAMP then regulates the activity of a number of 
enzymes (Butcher et al., 1968). 
In most cases, cAMP is associated with the cell membrane. Studies 
have shown this to be true for liver cells (Marinetti et al., 1969), fat 
cell ghosts (Rodbell et al. , 1968), and avian erythrocyte membrane (Oye 
and Sutherland, 1966). In characteristic target tissues and cells, sig­
nals (first messenger) activate a membrane-associated enzyme, adenyl 
cyclase, that converts adenosine triphosphate (ATP) to cAMP (Bar and 
Hechter, 1969). 
4. Cationic influences on insulin secretion 
The role of extracellular ions, especially cations, in cellular 
excitation has been extensively investigated. Normal nerve conduction 
or muscle contraction is associated with well documented movements of 
sodium and potassium across the cell membrane and depends, in a manner 
less well understood, on extracellular calcium (Hales and Milner, 1968). 
Many different secretory cells which store their product in granules or 
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vesicles need extracellular calcium for the normal release of the secre­
tion. Such diverse systems include the release of vasopressin from the 
neurohypophysis (Douglas and Poisner, 1953), the acetylcholine-stimu-
lated release of catecholamines from the adrenal medulla (Douglas and 
Rubin, 1961; Trifaro, 1959), and the ACTH-stimulated release of adrenal 
steroids from the adrenal cortex (Birmingham et al., 1953). Calcium 
ions also stimulate adenyl cyclase in isolated plasma membranes but the 
effect shows appreciable variability (Marinetti et al., 1959). The 
absolute requirement for extracellular calcium in insulin secretion has 
been demonstrated in the isolated perfused rat pancreas and in pieces 
of rabbit pancreas (Grodsky and Bennett, 1966; Milner and Hales, 1967). 
The role of other cations on insulin secretion has also been investigated. 
In vitro studies with pieces of rabbit pancreas have provided evi­
dence that a sodium pump plays a part in insulin secretion and that 
extracellular sodium is a prerequisite for secretion in response to a 
variety of stimuli. Insulin secretion may be associated with a rise in 
sodium concentration in the $-cell. It was suggested that depolariza­
tion and/or influx of sodium across the 3-cell membrane leads to insulin 
secretion. Potassium also enhanced insulin secretion although it was 
sodium dependent (Hales and Milner, 1968). 
Magnesium apparently is not essential for insulin secretion (Grodsky 
and Bennett, 1966). Later studies have shown a calcium-magnesium 
antagonism in insulin secretion. In the isolated perfused rat pancreas 
magnesium attenuated insulin secretion or abolished it entirely when the 
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magnesium concentration was much greater than calcium concentration of 
the perfusate (Bennett et al., 1969). However, the hypoglycemic effect 
of injected insulin was enhanced by calcium and magnesium in rabbit 
convulsion tests (Planchart, 1968). 
The necessity of calcium for insulin secretion has been shown 
(Grodsky and Bennett, 1966). The presence of only 0.2 mEq/L of calcium 
was adequate to permit slow insulin secretion by the perfused isolated 
rat pancreas, while normal calcium concentrations showed the usual in­
sulin response to glucose stimulus. Further in vitro studies have shown 
the insulin secretion response to a glucose stimulus to be nearly linear 
with the calcium concentration as high as 4- mEq/L and a plateau effect 
with higher calcium concentrations. However, insulin secretion rate re­
mains linear with the calcium concentration upward to 11 mEq/L when 
tolbutamide is used as a stimulus for insulin secretion (Curry et al., 
1968). Other investigators have verified the requirement of calcium in 
insulin secretion in vitro when glucose, tolbutamide, glucagon or 
caffeine were used to stimulate insulin secretion (Milner and Hales, 
1967; Lambert et al. , 1969). One exception of the calcium requirement 
for insulin secretion has been noted. When tolbutamide was used in the 
isolated perfused dog pancreas, insulin secretion proceeded in the pres­
ence or absence of calcium (Dobbs et al., 1969). The association of cAMP 
and calcium with the same hormonal response in various cases has been 
compared. 
The clear implication is (1) that all these processes are controlled 
in an identical fashion after the initial stimulus, (2) that cAMP and 
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calcium ion are the key elements in this process, and (3) that their 
effects are upon membrane structure and function (Rasmussen and Tenen-
house, 1968). The exact biochemical role of cAMP in various secretory 
processes has not been clarified. 
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III. MATERIALS AND METHODS 
A. Experimental Animals 
Swine used in this study were second generation specific pathogen-
free stock obtained from natural farrowing. These animals were main­
tained on a 16 percent protein ration used for growing pigs. 
Dairy cows (various breeds) reported in this study had developed 
spontaneous hypocalcemia (parturient paresis) just prior to or immedi­
ately after calving. These cows originated from dairy herds in Iowa 
and Minnesota. 
B. Surgical Preparations 
Female pigs, weighing 40 to 50 kilograms, were fasted 12 to 15 hours 
prior to surgery. The pigs were anesthetized with halothane, a volatile 
anesthetic, for cannulation of the blood vessels. 
The femoral artery and vein were cannulated using polyvinyl tubing^ 
(i.d. 0.067", o.d. 0.107"). The cannulas were then passed subcutaneously, 
with the aid of a long needle, along the flank and exteriorized in the 
lumbosacral region. Stopcocks were fitted to the cannulas and anchored 
with skin sutures (Fig. 1) (Dougherty et al., 1955). This placement of 
the stopcocks provided a satisfactory location for sanitation and ease of 
blood sampling. The cannulae were filled with heparinized saline to pre­
vent blood clotting and occlusion. Surgery was done 10 to 12 days before 
studies were conducted. 
^Medical Grade Vinyl Tubing, Becton, Dickinson and Co., Rutherford, 
New Jersey. 
Figure 1. A diagrammatic presentation of arterial catheterization. 
The femoral vein is cannulated by the same procedure. 
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The jugular veins of each cow were cannulated with polyvinyl tubing 
using local infiltration anesthesia. A 12-gauge needle was inserted 
into the jugular vein and polyvinyl tubing was passed through the needle 
and into the jugular vein. The needle was withdrawn, leaving the poly­
vinyl tubing inserted in the vein. The tubing was then anchored to the 
skin with sutures to prevent its withdrawal from the vein. The intra­
venous catheters were used for infusions and blood sampling. 
C. Infusion and Blood Sampling Procedures 
1. Solutions and infusions 
Glucose infusion The glucose solution (50 percent) was infused 
(automatic syringe) through the venous catheter at a steady rate through­
out the infusion period (5 to 10 minutes). The intravenous glucose 
tolerance test provided 0.5 grams of glucose per kilogram body weight. 
EGTA [ethylenebis-(oxyethylenenitril) tetraacetic acid] infusion 
The EGTA solution (0.1 M) was infused through the venous catheter by a 
peristaltic pump.^ Infusion rates ranged from 1 to 5 ml/min to control 
the titratable calcium concentration at the desired level. Plasma titrat-
able calcium determinations were made concurrently with the infusion 
(delay period approximately 8 to 10 minutes) to improve calcium regula­
tion. During the infusion period, approximately 300 to 400 ml of EGTA 
solution was given intravenously. 
^Model 600-1200, Harvard Apparatus Conçany, Inc., Dover, Massa­
chusetts . 
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Calcium infusion The calcium borogluconate was infused at a 
steady rate over a 10- to 20-minute period (0.5 ml/kg body wt. ; 23 per­
cent calcium borogluconate solution). 
Calcium borogluconate-EGTA infusion An equimolar calcium boro­
gluconate -EGTA solution (400 ml) was infused over a period of 90 minutes. 
Isotonic saline infusion An isotonic solution of saline (0.85 
percent NaCl; 400 ml) was infused over a period of 90 minutes. 
2. Sequence of infusions 
Cows Twelve cows were infused sequentially with glucose, cal­
cium borogluconate and glucose with approximately 100-minute intervals 
between each infusion. Included in this study were three cows in mid-
lactation, three cows 24-hour postpartum, three cows with mild post-
parturient paresis, and three cows with severe postparturient paresis. 
Eight cows with postparturient paresis were infused with calcium boro­
gluconate. Blood sarnples were collected at timed intervals before, 
during, and after each infusion. 
Pigs The pigs were conditioned to confinement crates prior to 
infusion studies so they would stand or lie quietly during the experi­
ment. The pigs were also fasted 16 to 18 hours prior to each experiment. 
The experimental situation is shown (Fig. 2). 
Several combinations of solutions were infused to provide the de­
sired experimental conditions: 
(1) EGTA infusion to induce hypocalcemia 
(2) Saline infusion, equivalent in volume and time to EGTA 
infusions 
(3) Calcium infusion to normocalcemic and hypocalcemic pigs 
Figure 2. A typical experimental situation showing the infusion 
pump and tubing connected to the stopcocks on the pig. 
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(4) Calcium-EGTA infusion in normocalcemic pigs 
(5) Glucose infusions in normocalcemic and hypocalcemic pigs 
(6) Glucose-calcium infusions in hypocalcemic pigs 
3. Blood sampling 
The catheter system provided one catheter (venous) for infusions 
and one catheter for blood sampling (swine-arterial, cow-venous). 
Approximately 4 ml of blood was withdrawn from the catheter (vol. 1.4 ml) 
and discarded before obtaining each blood sample. The heparinized blood 
samples were centrifuged immediately and the plasma separated for chemi­
cal determinations. The plasma was refrigerated immediately and stored 
(-40°F) at the end of the experiment in parafilm-stoppered test tubes. 
D. Analytical Procedures 
1. Glucose determination 
In this investigation plasma glucose levels were determined by the 
glucose oxidase method and the ferricyanide method (Keston, 1956; Hoff­
man, 1937). The glucose oxidase method consists of a coupled enzyme 
system suitable for the quantitative, colorimetric specific determina­
tion of glucose based on the following simplified scheme of reaction: 
glucose 
oxidase 
Glucose + O2 + H2O ^ H2O2 + gluconic acid 
peroxidase 
H2O2 + reduced chromogen ^ oxidized chromogen 
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The application of the combined reactions as a test for glucose was first 
proposed by Keston (1956). A mixture of the two enzymes and oxygen 
acceptor is available.^ 
The basis of the ferricyanide method for the determination of glu­
cose is the reduction of potassium ferricyanide to potassium ferrocyanide 
with the concomitant oxidation of glucose to gluconic acid and other 
products (Hoffman, 1937). This method has been automated and was used 
2 for glucose determinations in this study. For direct comparison of 
tests, the ferricyanide method of Hoffman, as used in the standard 
autoanalyzer procedure, the Somogyi modification of Nelson, and the glu­
cose oxidase methods can be considered equivalent, giving levels of 
true glucose (Joplin and Wright, 1968). 
In the present study, glucose concentrations on 67 paired samples, 
as determined by the glucose oxidase method and the ferricyanide method, 
averaged 87.20 mg/100 ml and 88.94 mg/100 ml, respectively. The 95 
percent confidence limits for the true difference between the two methods 
was -3.00 to 0.52. 
2. Insulin determination 
The standard curve for IRI was determined at each point by tripli­
cate analysis of the prepared standard. Plasma IRI concentration was 
assayed by duplicate determination of each plasma sample. 
^Glucostat Special, Worthington Biochemical Corp., Freehold, New 
Jersey. 
^Autoanalyzer^^, Technicon Corp., Ardsley, New York. 
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The radioiiranunoassay determinations of insulin were done according 
to the method of Hales and Randle (method C, 1963). Commercially 
available iodinated insulin and insulin binding agent (double 
antibody system) were utilized in the radioimmunoassay.^ Glucagon-free 
porcine insulin (23.9 units/mg) for standard reference was kindly 
2 
supplied by Eli Lilly and Company. 
The precipitate with the bound insulin was separated from residual 
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unbound insulin by micro-filtration. Bovine albumin (Fraction V) 
buffer solution was used for washing during the filtration process. The 
albumin buffers must be handled carefully during pipetting and washing 
to avoid excessive foaming, since excessive foaming usually leads to a 
considerable error in the radioimmunoassay. 
The process of washing for separation of bound and unbound insulin 
was time-consuming, so a semi-automated procedure was developed which 
improved the accuracy of the immunoassay and doubled the washing rate 
(Fig. 3). The device was fabricated from the upper glass section of 
the standard Millipore filter holder. An automatic diluter delivered 
the albumin buffer during washing.^ 
^Nuclear-Chicago Corp., 2000 Nuclear Drive, Des Plaines, Illinois. 
^The Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, 
Indiana. 
^Millipore Filter, 0.45 y, catalog No. HAWG 02500, Millipore Filter 
Corp., Bedford, Massachusetts. 
^Pyrex Filter Holder, catalog No. XX1002500, Millipore Filter Corp., 
Bedford, Massachusetts. 
^York Automatic Diluter, Model LD-1, York Instrument Co., 150 5th 
Ave., New York, New York. 
Figure 3. Equipment array as utilized for separation of bound 
labeled insulin from free labeled insulin (upper). 
Washing apparatus with test tube, which contained sample, 
inverted over discharge nozzle (lower). 
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The washing procedure was carried out as follows: 
(1) 1.5 ml of buffer added to the sample and mixed gently. 
(2) Test tube containing the diluted sample was inverted over 
the washing device. 
(3) Two 4-ml washes with buffer delivered by automatic diluter. 
(4) Filter containing bound insulin complex was transferred to 
scintillation vial. 
(5) Washing device rinsed with deionized distilled water and 
ready for next sanple. 
The liquid scintillation medium consisted of jqrlene, dioxane, and 
cellosolve described by Bruno and Christian (1961). A liquid scintilla­
tion spectrometer was used-for radioactivity.determination.^ The 
insulin concentration of the unknown samples were determined from the 
standard reference curve (counts/min vs. insulin concentration) that 
was made with each batch of insulin determinations. A typical standard 
curve is shown (Fig. 4 ). The pooled estimate based on 60 duplicates of 
the within sample standard error was 7.20 yU/ml. 
3. Titratable calcium determination 
Titratable calcium was determined by a simple and precise micro-
method for ethylenediaminetetraacetate (EDTA) titration of calcium (Copp, 
1963). This is essentially a photometric titration with EDTA, with 
ammonium purpurate as the indicator. 
^Tri-Carb Liquid Scintillation Counting System, Model 314EX, Packard 
Instrument Co., Inc., Box 428, LaGrange, Illinois. 








In strongly alkaline solution, the maxim-urn absorption for the cal-
cium-purpurate complex appears at 505 to 510 my, while the maximum 
absorption peak for the piai*purate ion in the absence of calcium occurs 
at 550 my. The difference is too small to provide a suitable visual 
endpoint, but can be readily adapted to photometric titration with a 
500 to 510 my filter. As EDTA is added, removing the calcium from the 
purpurate conçlex, light transmittance will increase rapidly. If the 
increasing light transmittance is plotted against EDTA added,a sharp 
break in the curve will be observed at the endpoint. With a photo­
electric colorimeter, the increase in potential from the photocell 
associated with the increased light transmittance can be recorded on a 
millivolt potentiometric recorder, indicating the endpoint as a break 
in the recorded curve. Since the EDTA was added at a constant rate 
and the recorder paper speed was constant, the distance on the recording 
paper between the beginning of the EDTA infusion and the endpoint is a 
function of calcium concentration. The typical standard curve is shown 
(Fig. 5 ). The apparatus used in this study for titratable calcium 
determination consisted of a constant rate syringe burette,^ a spectro­
photometer,^ a strip chart recorder,^ and a magnetic stirrer'^ (Fig. 6 ). 
^Sargent Constant Rate Burette, Model C, S11120, E. H. Sargent and 
Co., Chicago, Illinois. 
^"Spectronic 20", Bausch and Lomb, Inc., Rochester, New York. 
^Linear/log varicord. Model 43, Photovolt Corp., New York, New York. 
^Explosion-proof magnetic stirrer, catalog No. 24801312, The 
Chemical Rubber Co., 18901 Cranwood Parkway, Cleveland, Ohio. 
Figure 5. A standard curve for titratable calcium concentration showing EDTA 
titration as a function of calcium concentrations (5 experiments). 
Each point represented by mean ± SE. 
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A stock solution^ was diluted to provide calcium standards of appro­
priate concentration. 
4. Total calcium determination 
The atomic absorption technique (Willis, 1960) is based on the 
fact that the atoms of every element can absorb radiation at very narrow 
wavelength bands which are different for each element. In order to be 
in a condition to absorb, the atoms must be chemically unbound and in 
their minimum energy state; in general, this condition is achieved by 
vaporizing the sample in a flame. The particular advantage of atomic 
absorption is that only a small fraction of atoms will be raised to 
high energy states even when subjected to high temperatures. Thus, 
samples which are thermally reduced to the atomic state are analyzed by 
the absorption state with only a slight temperature influence. The 
intensity of absorption is related quantitatively to the concentration 
of metal in the flame. 
The source or radiation is generally a hollow cathode lamp, whose 
cathode is made of the element being determined, and which emits the 
line spectrum of that element. Atomic absorption obeys Beer's Law: 
concentration of the element in the sample being proportional to the 
absorbance (optical density, log transmittance) in the flame. 
Lanthanum (0.05 percent) was used in the sample preparation to 
reduce phosphate interference of calcium absorption. The unknown 
^Calcium flame photometry std. C, 100 mEq/1000 ml, item #3765, 
Hartman Leddon Company, Philadelphia, Pennsylvania. 
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sample absorbance was compared to known standard absorbance for deter-
1 2 
mination of calcium concentration. A standard calcium stock solution 
was diluted to provide standards of appropriate concentration. 
E. Analog Computer Simulation 
A mathematical model was proposed which depicts the glucose-insulin 
relationship during the intravenous glucose tolerance test in normocal-
cemic and hypocalcemic (induced) pigs. The biological data from the 
intravenous glucose tolerance tesT provided the reference points during 
analog computer simulation. The equations of regulation were normalized 
3 
and programmed on the analog computer. 
The mathematical model and analog computer simulation data are pre­
sented in "Results and Discussion" to facilitate ease of presentation 
to the reader. 
^Atomic absorption spectrophotometer, Model 290, Perkin-Elmer Corp., 
Norwalk, New Jersey. 
^Calcium flame photometry std. C, 100 mEq/1000 ml, item #3765, 
Hartman Leddon Conpany, Philadelphia, Pennsylvania. 
^Analog computer. Model TR20, Electronic Associates, Inc., West 
Long Branch, New Jersey. 
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IV. RESULTS AND DISCUSSION 
A. Effect of Spontaneous Hypocalcemia on Insulin Secretion 
in the Dairy Cow 
1. Plasma concentrations of glucose, IRI, and total calcium in asso­
ciated physiologic states 
The concentrations of glucose, IRI, and total calcium in plasma of 
normal lactating cows, normal 24- to 48-hour postparturient cows, and 
cows with mild and severe postparturient paresis are shown (Table 1). 
The results of the contrasts of the various groups are also shown (Table 
1). When postparturient cows and those with mild postparturient paresis 
were grouped and congared with normal lactating cows (contrast B), there 
were significant decreases in plasma concentrations of calcium and IRI 
in postparturient cows, but no significant difference in glucose. How­
ever, there were no significant differences in the plasma concentrations 
of glucose or insulin of postparturient cows and cows with mild post­
parturient paresis (contrast A), but the calcium concentrations were 
significantly decreased in the latter group. When cows with severe 
postparturient paresis were compared with all other cows taken as a 
group (contrast E), -there were significant decreases in. plasma concen­
trations of calcium and a significant increase in glucose, but no detect­
able difference in IRI of cows with severe postparturient paresis. 
2. Variations in plasma concentrations of glucose, IRI, and total calcium 
during infusion studies 
The typical response to intravenous infusions of 500 ml of 50 per­
cent glucose and 500 ml of 23 percent calcium borogluconate of a normal 
cow (cow A) (Fig. 7) in midlactation was compared with that of a clini­
cally normal postparturient cow (cow B) (Fig. 8). Glucose levels in 
Table 1. Mean concentrations of glucose, IRI, and total calcium in plasma of normal lactating 
cows (N), 24- to 48-hour postparturient cows (PP), cows with mild postparturient 
paresis (MPP), and cows with severe postparturient paresis (SPP), and contrasts of 
the means.B 
Mean i S.E. of mean Contrasts^ 
N (8)^ PP (3) MPP (3) SPP (6) ABC D E 
Glucose 70.3 ± 0.2 74.0 ± 18.2 68.8 ± 18.2 161.0 ± 12.8 NS NS * * * 
(mg/100 ml) 
IRI (porcine 78.9 ± 7.2 40.6 ± 9.6 47.8 ± 9.6 62.1 ± 7.2 NS * NS NS NS 
yU/ml) 
Ca (mEq/L) 4.7 ± 0.1 3.9 ± 0.15 2.75 ± 0.15 1.75 ± 0.25 A A A A A 
^Key to contrasts: A = PP vs. MPP; B = N vs. PP; C = PP and MPP vs. SPP; D = N vs. SPP; 
E = N, PP, and MPP vs. SPP. 
^Significance:* = statistical significance at the .05 level; NS = not statistically 
significant at the .05 level. 
^Number of animals. 
Figure 7. Effect of intravenous infusions of glucose or calcium 
borogluconate on the plasma concentrations of imrauno-
reactive insulin in a lactating cow. Each point re-
presented by mean value. 
EZZZ3 Infusion period of respective substance. 
CALCIUM mEq/l GLUCOSE mg/lOO ml 
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Figure 8. Effect of intravenous infusions of glucose or calcium 
borogluconate on the plasma concentrations of iiranuno-
reactive insulin in a 24-hour "normal" postparturient 
cow. Each point represented by mean value. 
E23 Infusion period of respective substance. 
CALCIUM mEq/l GLUCOSE mg/lOO ml 
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plasma of the cow in midlactation approximated pre-infusion concentra­
tions within 90 minutes after infusion of 250 grams of glucose. This 
response occurred both before and after infusion of calcium. Plasma 
concentrations of immunoreactive insulin increased 4- to 5-fold within 
10 minutes after the start of each infusion of glucose. No increase in 
immunoreactive insulin was detected following administration of calcium 
borogluconate to the normoglycemic cow. Glucose tolerance curves and 
immunoreactive insulin response of the normal postparturient cow were 
essentially the same as the cow in midlactation. 
The response to intravenous infusions of calcium and glucose into 
cows with postparturient paresis (cows C and D) is shown (Figs. 9 and 
10). In contrast to the values of the normal cows shown (Figs. 7 and 
8), cow C was hyperglycemic prior to infusion and had a prolonged glu­
cose tolerance curve. Furthennore, the prompt increase in plasma con­
centrations of immunoreactive insulin was not observed following the 
first infusion of glucose. However, infusion of calcium borogluconate 
evoked a prompt rise in immunoreactive insulin. Glucose infusion 100 
minutes after infusion of calcium caused an additional rise in immuno­
reactive insulin and the glucose tolerance curve was similar to that 
observed in the normal cow. 
Cow D also showed a markedly diabetic glucose tolerance curve and 
a subnormal immunoreactive insulin response to intravenous glucose ad­
ministration, whereas a 3-fold increase in plasma concentrations of IRI 
was observed after infusion of calcium. Although glucose infused 100 
minutes after calcium treatment did result in an increase in IRI, the 
Figure 9. Effect of intravenous infusions of glucose or calcium 
borogluconate on the plasma concentrations of immuno-
reactive insulin in a cow with severe postparturient 
paresis (cow C). Each point represented by mean value. 
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Figure 10. Effect of intravenous infusions of glucose or calcium 
borogluconate on the plasma concentrations of immmo-
reactive insulin in a cow with severe postparturient 
paresis (cow D). Each point represented by mean value. 
EZZ3 Infusion period of respective substance. 
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glucose tolerance curve was not restored to normal and a severe hyper­
glycemia persisted for the duration of the sampling period. The secre­
tion of IRI by cow D after the calcium therapy and the second glucose 
pulse was typically diabetic (mild), i.e. a slow somewhat delayed onset 
of insulin release followed by nearly normal amount of total insulin 
secretion. A similar response has been noted in the isolated, perfused 
rat pancreas. The results of adding calcium after 40 minutes of per­
fusion with a calcium-free perfusate were somewhat equivocal in that 
two of four preparations clearly secreted insulin, whereas the other two 
did not (Curry e^ al., 1968). It thus appears that the inhibition of 
insulin secretion by calcium lack is reversible in its early stages 
but that ultimately may become irreversible (Curry e^ al., 1968). 
Cows with postparturient paresis were infused with calcium boro-
gluconate to test its effect on concentrations of IRI. A typical re­
sponse of a cow with severe parturient paresis following treatment with 
calcium borogluconate is shown (Fig. 11). A marked rise in the concen­
tration of immunoreactive insulin was observed, which was maintained 
for approximately 2 hours. During this interval, there was some de­
crease in plasma glucose concentration but the plasma glucose remained 
well above normal concentrations despite the observed increase in 
immunoreactive insulin. 
The results of this study indicate that cows with severe postpar­
turient paresis had a gross alteration in the hormonal regulation of 
plasma glucose. This deficiency was reflected in the relatively low 
insulin levels in the plasma of the parturient paretic cows which showed 
Figure 11. Effect of intravenous infusion of calcium borogluconate 
on the plasma concentrations of glucose and iirammo-
reactive insulin in a cow with severe postparturient 
paresis. Each point represented by mean value. 
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extreme hyperglycemia. It was also reflected by the prolonged glucose 
tolerance curve and by the inability to secrete normal amounts of IKE 
in response to an infusion of glucose. Inability to secrete normal 
amounts of IRI in response to hyperglycemia appeared to be related to 
the extremely low concentration of calcium in plasma. In the presence 
of hyperglycemia following glucose infusion or in the presence of hyper­
glycemia found naturally in postparturient paresis, calcium infusion 
caused a marked increase in plasma concentrations of IRI. In some 
instances, the onset of IRI secretion was abrupt and indicative of a 
normal response,and in other cases it was slightly delayed and a slower 
rise in IRI secretion which is typical of the mild diabetic (man). Thus, 
the calcium requirement for the secretion of insulin demonstrated by 
Grodsky and Bennett (1966) in vitro has been shown to occur in vivo in 
a spontaneous hypocalcemic syndrome of cattle. Therefore, it is con­
cluded that the repression of insulin secretion induced by hypocalcemia 
and its effect on metabolism assume physiopathologic significance 
(Littledike et al., 1968). 
B. Effect of Induced Hypocalcemia on Insulin 
Secretion in the Pig 
In order to improve our understanding and to further verify the 
necessary role of calcium in insulin secretion, a series of experiments 
were conducted in pigs. 
In the series of control experiments various combinations of solu­
tions were infused to verify that these substances did not elicit IRI 
secretion. The control experiments consisted of two pigs in each group 
which were treated as follows; 
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Group I — Infusion of calcium borogluconate-EGTA solution 
Croup IT — Infusion of EGTA solution 
Group III — Infusion of calcium borogluconate solution to normo-
calcemic and hypocalcemic pigs 
Group IV — Infusion of isotonic saline 
Group V — No treatment given. 
The glucose tolerance test (10-minute infusion period) was conducted 
on eight normocalcemic pigs to establish a quantitative basis for in­
sulin secretion. Thereafter, the glucose tolerance test was conducted 
with four hypocalcemic pigs (two pigs, 5-minute infusion period; two 
pigs, 10-minute infusion period). The last experiment of the series was 
conducted on two hypocalcemic pigs. In this case, calcium borogluconate 
was mixed with the glucose solution and infused to restore the plasma 
calcium to pre treatment levels simultaneously with performance of the 
glucose tolerance test. 
1. Physiologic responses during infusions in control studies 
Calcium borogluconate-EGTA infusion A mixture of calcium boro­
gluconate and EGTA was infused to determine if this combination would 
affect the basal concentrations of plasma IRI or glucose. Since EGTA 
will chelate calcium in equimolar amounts, the combined solution should 
not alter the normocalcemic state directly. It can be seen that the 
calcium-EGTA infusions did not appreciably disturb the plasma IRI, glu­
cose or titratable calcium concentrations (Fig. 12). 
EGTA infusion The infusion of EGTA was regulated at 4 to 6 ml 
per minut^ to induce the desired hypocalcemic state; thereafter, the 
Figure 12. Effect of intravenous infusion of an equimolar solution 
of calcium borogluconate and EGTA on the plasma concen­
trations of glucose, immunoreactive insulin and titratable 
calcium in normocalcemic pigs. Each point represented 
by mean value. 
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infusion rate was reduced 30 to 40 percent to maintain the desired 
plasma calcium concentration (1.2-2.0 mEq/L). Titratable calcium deter­
minations were made immediately after collecting each blood sample. 
This determination required approximately 8 minutes and was used as an 
index for adjusting the EGTA infusion rate. Thus, it was relatively 
simple to control the hypocalcemia state. Initial experiments without 
the titratable calcium determinations resulted in fluctuating plasma 
calcium concentrations and one could not regulate the hypocalcemia state 
satisfactorily. The average concentrations of glucose, insulin and 
titratable calcium are shown (Fig. 13). It should be noted that the 
plasma glucose concentration remained relatively constant throughout the 
e^qseriment. The pigs'usual response to induced hypocalcemia was a pro­
gressive state of lethargy; however, sporatic excitability was noted 
occasionally. As the plasma titratable calcium concentration approached 
lower levels, the pigs started chewing movements and, if standing, developed 
a pronounced ataxia. The forelimbs tended to remain in a slightly 
flexed position when the plasma calcium concentration was 1.5 mEq/L. 
When the EGTA infusion was discontinued, the titratable calcium re­
turned to initial levels within 20 to 30 minutes. No apparent side 
effects were noted following recovery from EGTA infusions. 
Calcium infusion The calcium borogluconate was infused to deter­
mine if it would affect the basal concentrations of glucose or IRI. The 
average concentrations of glucose, IRI, and titratable calcium are shown 
(Fig. 14). The titratable calcium has increased from 4.5 mEq/L to 7.9 
mEq/L. Again, one will note no other appreciable changes in plasma IRI 
Figure 13. Effect of intravenous infusion of EGTA on the plasma con­
centrations of glucose, immunoreactive insulin cind ti-
tratable calcium in normocalcemic pigs. Each point re­
presented by mean value. 
EZZ3 Infusion period. 
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~ ro w 
o o o 0) O o 5 o 
i I I L_ 
GLUCOSE mg/lOOmI 
8 8 8 
1 1 1 
Figure 14. Effect of intravenous infusion of calcium borogluconate 
on the plasma concentrations of glucose, immunoreactive 
insulin and titratable calcium in normocalcemic pigs. 
Each point represented by mean value. 
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glucose concentrations. The typical response of induced hypocalcemic 
pigs to calcium infusions is also shown (Fig. 15). The titratable 
calcium has been increased from 1.8 mEq/L to 7.2 mEq/L. As before, no 
appreciable changes in plasma IRI or glucose have occurred. 
Saline infusions Saline (0.85 percent NaCl) was infused in a 
comparable rate and volume as EGTA to determine the effect of fluid 
volume changes, if any, on the plasma IRI, glucose and titratable cal­
cium concentrations. The average concentrations of glucose, insulin 
and titratable calcium are shown (Fig. 16). The infusion of 300 to 400 
ml of saline during a 110-minute period did not alter the normal physio­
logic state perceptibly. 
No treatment period During this period of observation only 
blood samples were drawn at timed intervals. The pigs remained quiet, 
as usual, and only slight fluctuations in plasma glucose, insulin and 
titratable calcium are noted (Fig. 17). 
While two animals in each group do not permit an adequate statistical 
analysis, it was obvious that no appreciable changes occurred in plasma 
concentrations of glucose or IRI during the control experiments. Thus, 
the individual groups may be compared in essence as a composite group. 
The preceding infusions of EGTA, saline, calcium, and calcium-EGTA 
have provided the basic "controls" in this series and indicate that dis­
turbances in IRI secretion as observed in hypocalcemic states was not 
due to effect of the solutions per se but rather to the existing hypo­
calcemic state. 
72b 
2. Alterations in plasma concentrations of IRI during intravenous glu­
cose tolerance test in normocalcemic and hypocalcemic states 
Glucose infusion The representative response of eight normo-
calcemic pigs to the intravenous glucose tolerance test is shown (Fig. 
18). Within 10 minutes the plasma glucose has increased to 294- mg/100 ml. 
Figure 15. Effect of intravenous infusion of calcium boroglaconate 
on the plasma concentrations of glucose, imnuno-
reactive insulin and titratable calcium in hypocs.lc&mic 
pigs. Each point represented by mean value. 
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Figure 16. Effect of intravenous infusions of saline solution 
(0.85 percent NaCl) on the plasma concentrations of 
glucose, immunoreactive insulin, and titratable cal­
cium in normocalcemic pigs. Each point represented 
hy mean value. 
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Figure 17. Plasma concentrations of glucose, immunoreactive insulin 
and titratable calcium in normocalcemic pigs during the 
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Figure 18. Effect of intravenous infusions of glucose on the 
plasma concentrations of glucose, immunoreactive 
insulin and titratable calcium in normocalcemic pigs. 
Each point represented by mean value ± SE. 
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and the I RI has increased 5-fold within 15 minutes. The plasma glu­
cose and IRI concentrations have returned to pre treatment levels within 
30 and 40 minutes, respectively. After the plasma glucose has returned 
to pre treatment levels, it continued to decline to a low level of 64 
mg/100 ml (average 57 rag/100 ml) in 40 minutes, while at 90 minutes the 
glucose was usually slightly below the pretreatment level. 
The response of hypocalcemic (induced) pigs to the intravenous 
glucose tolerance test is shown (Figs. 19 and 20), At the end of the 
glucose infusion period the plasma glucose concentration has peaked, 
similar to the normocalcemic pigs, and the plasma IRI concentration has 
increased only 1.5-fold within 15 minutes, which is the highest concen­
tration attained during the experimental period. In general, there is 
a slight release of insulin in this group of pigs. The suppression of 
insulin secretion was produced with a sustained plasma titratable cal­
cium of 1.25-1.95 mEq/L. The plasma glucose has not returned to pre­
treatment levels at 90 minutes after glucose infusion, but remained 
about 15 mg/100 ml above the "normal" of this group. The 5-minute 
in inision period produced a higher peak plasma glucose concentration. 
However, curve fitting of the post-infusion period (glucose) showed no 
significant difference in the rate of glucose assimilation (Fig. 21). 
Plasma glucose concentrations, during the post-infusion period, from 
the two hypocalcemic groups were fit by the method of least squares to 
quadratic equations. No significant departure from parallelism was 
noted. The final equations for the 5-minute and 10-minute glucose in­
fusion groups were, respectively: 
Figure 19. Effect of intravenous infusion of glucose (5-minute) on 
the plasma concentrations of glucose, immunoreactive 
insulin and titratable calcium in hypocalcemic pigs. 
Each point represented by mean value. 
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Figure 20. Effect of intravenous infusion of glucose (10-minute) on 
the plasma concentrations of glucose, immunoreactive 
insulin and titratable calcium in hypocalcemic pigs. 
Each point represented by mean value. 
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Figure 21. Plasma concentrations of glucose during the post-infusion periods 
following 5-minute and 10-minute glucose infusion periods. Each 
point represented by mean value. 
0—0—0 Post-infusion period following 5-minute glucose 
infusion 
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(1) glucose = 303.62-(4.08 + .195)t + (.0288-.0042)t^ 
- (2) glucose = 238.43 - 4.08t + .0288t^ 
The plasma glucose concentrations for a corresponding time period were 
significantly different as one can observe (Fig. 21). However, the 
glucose disappearance rate was not significantly different. 
Glucose-calcium borogluconate infusion The responses of two 
hypocalcemic (induced) pigs to an intravenous glucose-calcium infusion 
is shown (Fig. 22). The simultaneous administration of calcium with 
glucose was used to correct the hypocalcemic state. Within 10 minutes 
the plasma glucose has increased to 261 mg/100 ml, and the plasma IRI 
has increased 4-fold within 15 minutes. The plasma titratable calcium 
has increased from 2.2 to 5.0 mEq/L; within 90 minutes the titratable 
calcium returned to pretreatment levels. The plasma glucose has re­
turned to pretreatment levels within 35 minutes which was comparable to 
the normocalcemic pigs; however, it required an excess of 90 minutes in 
the hypocalcemic pigs. 
During the glucose tolerance test, in hypocalcemic pigs the plasma 
glucose levels do not return to pretreatment levels within 90 minutes, 
while in the normocalcemic pigs and the calcium corrected hypocalcemic 
pigs the plasma glucose has returned to pretreatment levels within 40 
minutes or less. The plasma IRI increased approximately 1.5-fold in 
hypocalcemic pigs, over 5-fold in the normocalcemic pigs and 4-fold in 
calcium corrected hypocalcemic pigs. Thus, following calcium replacement 
in the hypocalcemic pigs the glucose tolerance curve and insulin secre­
tion have been essentially reversed to that of normocalcemic pigs. 
Figure 22. Effect of intravenous infusion of a solution containing 
calcium borogluconate and glucose on the plasma con­
centrations of glucose, immunoreactive insulin and 
titratable calcium in hypocalcemic pigs. Each value 
represented by mean value. 
EZZZZI Infusion period. 
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The exact mechanism by which calcium acts on insulin release is 
not known. However, changes have been noted in the 8-cell transmembrane 
potential following specific stimuli for insulin release (Dean and 
Matthews, 1968). Agents which stimulate secretion, namely, tolbutamide, 
L-leucine and glucose, rapidly induce changes in the electrical activity 
of the islet cell membrane; action potentials being produced. An ionic 
requirement for Na"*" and Ca** ions has been shown to be necessary for 
insulin secretion; thus, if the ionic theory of electrical activity in 
nerve and muscle holds also for islet cells, it is possible that these 
stimulants to insulin secretion may first affect the biophysical pro­
perties of the S-cell membrane leading to a transmembrane flux of 
sodium and calcium ions. This ionic flux may then accelerate the 
mechanism for insulin secretion. 
C. Mathematical Modeling 
Mathematical evaluation of the glucose-insulin regulatory mechanism 
based on feedback theory has been studied by several investigators 
(Bolie, 1960, 1961; Seed et al., 1962; Belisles, 1962; Schrunk, 1963; 
Ackerman et al., 1964, 1965; Janes and Osbum, 1965; Brodan, 1966; Camp­
bell, 1967; Cerasi, 1967; Ceresa, 1968; Silvers e^ , 1969). Data 
from experiments in which the infusion of exogenous insulin and the 
determination of insulin concentrations by bioassay techniques has been 
used for most mathematical models. Currently, the determination of 
insulin concentrations by radioimmunoassay techniques provides more pre­
cise values than obtained from bioassay. The biological activity of 
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endogenous insulin may differ from exogenous insulin; thus, comparison 
of quantitative data from these two types of insulin may be somewhat 
misleading. 
In this series of experiments the insulin was determined by the 
radioimmunoassay technique, and the glucose-insulin relationship was 
evaluated during its transient state. Therefore, it was of interest 
to propose and evaluate a mathematical model for analog simulation of 
glucose-insulin relationship during the transient state. 
1. Equations of regulation 
A minimum in mathematical complexity is achieved by utilization of 
a single compartment model which is restricted to the functions of the 
liver, pancreas, peripheral tissues and kidney. This system does not 
account for intravascular-extravascular differences in concentrations 
of insulin and glucose. The results predicted by solving these equa­
tions should be similar to those of Bolie (1961), with one exception. 
The proposed model used in this study simulates the renal threshold 
for glucose and thus should be valid for blood glucose concentrations 
from 30 mg/100 ml to 400 mg/100 ml, or even higher values of blood 
glucose. 
The anailysis is limited to short-term actions of the liver, pan­
creas, kidney and tissues which regulate blood glucose concentrations. 
The resolution in time and space does not account for incomplete mixing 
of glucose or insulin with the blood and extravascular fluid. The 
assumptions which limit the scope of the problem are listed in Table 2 
(Bolie, 1960). 
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Table 2. Assumptions^^ 
1. The hypothalamic control of the pancreas via the vagus nerve is of 
negligible consequence. 
2. The extent of glucose synthesis by the kidney is negligible under 
the conditions considered. 
3. The rate of gluconeogenesis does not vary appreciably during the 
time interval considered. 
4. There is no appreciable time delay in the response of the liver, 
pancreas, kidney, and tissues to changes in blood levels of glucose 
or insulin. 
5. The exchanges of glucose and insulin between the blood stream and 
the extravascular fluid are passive processes of transcapillary dif­
fusion, and exchanges are rapid enough that the extravascular and 
intravascular compartments may be considered as a single compartment. 
6. The sympathetic nervous system plays no important role in glucose 
regulation under the conditions considered. 
7. There is no intestinal absorption of glucose during the time inter­
val considered. 
8. The effects of changes in the rate of glucagon secretion, if any, are 
simply to proportionally reduce the dominant effects of insulin. 
•J. In the mathematical analysis and in the evaluation of the coefficients, 
fluctuations in insulin and glucose levels are restricted to small 
values, so that linear differential equations apply. 
10. Phenomena requiring gradations finer than 5-minute intervals for 




These assumptions are justified on the basis of published experi­
mental data. However, the assumption that the effects of changes in 
the rate of glucagon secretion, if any, are simply to reduce propor­
tionally the dominant effects of insulin is no longer feasible. More 
recent experimental evidence has shown that glucagon stimulates the 
release of insulin directly (Samols et al., 1966). The animals used 
in our series of studies were fasted before and during the experiment 
so one would not expect a significant change in glucagon. 
The glucose space in the rabbit and man, as determined with labeled 
glucose, was similar to the thiocyanate space (Wick et al., 1950; Seed 
et al., 1952). Therefore, the thiocyanate space (extracellular com­
partment) will be used to represent the glucose space of other species. 
The sodium thiocyanate space of mature cattle and swine is approximately 
30 percent of body weight (Hix et al., 1959; Kunesh, 1966). 
Primary and secondary nomenclature of equations are listed, re­
spectively (Tables 3 and 4). The differential equations of regulation 
may be written as: 
= - Fj^d) + FgfG) (1) 
^ Il = G - Fgd.G) - Fi^(I,G) - FgCG) (2) 
When the insulin and glucose fluctuations are limited to small 
physiologic variations, the above equations may be linearized in accord 
with well-known mathematical techniques (Bolie, 1961). In this case, 
the secondary nomenclature can be used. The differential equations of 
regulation now become; 
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Table 3. Primary nomenclature (modified)'^ 












Glucose S insulin space 
(extracellular fluid space) 
jRate of glucose infusion 
Plasma insulin concentration 
Plasma glucose concentration 
Rate of insulin destruction 
Rate of insulin production 
Rate of liver accumulation 
of glucose 
Rate of tissue utilization 
of glucose 




















Table 4. Secondary nomenclature (modified)^ 
Symbol Meaning Dimension 
lo Mean plasma conc. of I UUnits/ml 
Go Mean plasma conc. of G Mg/100 ml 
i i = I-Io yUnits/ml 
g g = G-Gq Mg/100 ml 
q q = G 
V 
Mg/100 ml/min 
a a = 1 3Fi 
V 9r lo 
Min"^ 
6 6 = 1  3 F 2  
V 3G Go 
10^ yUnits/ 
min/mg 






6 6 = 1 ^  
V 3G 
+ 3 Fa 
3G IoïGQ 
Min"^ 
a 0 = 1  3 F i i  




= - ai + eg (3) 
2P= q - yi - Gg - a[(g-100)y(g-100)] (4) 
The "regulatory coefficients" a, 8, y, ô and a denote, respectively, 
the sensitivity of insulin degradation to insulin concentration, the 
sensitivity of pancreatic insulin secretion to glucose concentration, 
the combined sensitivity of liver glycogen storage and tissue glucose 
utilization to insulin concentration, the combined sensitivity of liver 
glycogen storage and tissue glucose utilization to glucose concentra­
tion, and the sensitivity of the kidney to glucose excretion which is 
applicable to glucose concentrations above the renal threshold. 
2. Analog simulation 
The following normalized equations were utilized during analog 
simulation. 
The "regulatory coefficients" are related to the normalized equa­
tions and in turn to the potentiometers of the analog computer (Table 5). 
Subscript "c" denotes computer relationship of the labeled element. 
(5) 
dgc(T) , = K Ciic(T) - Uc(t--167)3 
dx '400 
( 6 )  
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Table 5. Relationship of coefficients to analog computer potentiometer 
Regulatory coefficient Analog coefficient Analog computer poten­
tiometer number 
a Ky 7 
6 Kg 5 
Y Kig 19 
6 Kg 3 
cr Ka 4 
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The computer time (x) in seconds is related to problem time (t) in 
minutes by: T = 6t 
where 3 = 1/60 for this simulation. 




Mcf /gc(T)/ \ - .25^ 
\\ '400 
or = 0 if 
-  • " )  '  °  
The glucose input for the computer Q cCt) was simulated by a step 
function generator. The glucose pulse was represented by the following 
term from equation (6): 
qc(T) = KiDpcCr) " Pc(t-.16?0 (?) 
Since ycCx) = 1, then -yc(T-.167) = -1 for T greater than 0.167. The 
simulated glucose pulse is represented by the following curve: 




Thus, T of .167 second represents the 10 minutes of glucose infusion. 
A schematic of the analog model is shown (Fig- 23). 
The analog computer output which simulated glucose and insulin for 
the normocalcemic pigs are compared to the ^  vivo data, respectively 
Figure 23. A schematic of the analog computer. 
-D>- inverter 
-[>- integrator 




S J sum junction 








(Figs. 24 and 25). The simulation data of glucose concentration remains 
within one standard error of the animal experimental data at all points. 
However, the simulation data of insulin was outside the range of one 
standard error of the ^  vivo data at 2 points. The magnitude of the 
simulation data for insulin is similar but has a slight phase shift 
when compared to the ^  vivo data. Perhaps a more precise simulation 
of the glucose-regulatory system could be achieved by further para­
meter adjustment or use of an expanded model with added degrees of 
freedom to improve the fit of model output to physiologic output. 
The simulated insulin output was reduced (potentiometer 5, Fig. 
23) to represent the hypocalcemic state in which insulin secretion is 
greatly or totally suppressed. The simulated glucose output can be 
compared to the physiologic response (Figs. 24 and 26). In this case, 
the simulated glucose response exhibits a slight phase shift. 
The "coefficients of regulation" for computer simulation (normo-
calcemic state) were determined as 5.00, 9.85, 2.3, 1.75 and .600 for 
a, 6, Y5 "5 and a, respectively. 3 was determined to be between 0.0 
and 0.75 for computer simulation during the hypocalcemic state; the 
other coefficients were not changed. 8 was adjusted to simulate vari­
ous levels of insulin secretion; the changes in the simulated glucose 
and insulin output are shown (Figs. 27 and 28). While these values 
differ considerably from other models it was believed to be a reason­
able approximation for the transient state simulated. Ultimately, 
however, it was recognized that insulin outputs are truly comparable 
only when expressed as responses to the same glycemic stimulus. It 
Figure 24. Output from analog computer during simulation of 
glucose and insulin (-»•) response to the intravenous 
glucose tolerance test in normocalceraic pigs (3 = 
9.85, upper photo) and in hypocalcemic pigs (3 = 
0.75, lower photo). 

Figure 25. Comparison of the analog computer simulation data and 
the in vivo data (Avg. ± S.E.) during the intravenous 
glucose tolerance test in normocalcemic pigs. 
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Figure 26. Comparison of the analog computer simulation data with the in vivo 
data during the intravenous glucose tolerance test in hypocaTcemic 
pigs. 3 was adjusted to 0.0 to completely suppress simulated 
insulin output. 
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Figure 27. Output from analog computer during simulation of 
glucose and insulin (-*•) response to intravenous 
glucose tolerance test. $ was adjusted to 6.35 
(upper photo) and 3.17 (lower photo) to reduce 
simulated insulin output. 
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Figure 28. Output from analog computer during simulation of glucose 
and insulin (-*•) response to intravenous glucose toler­
ance test. 3 was adjusted to 1.50 (upper photo) and 
0.0 (lower photo) to reduce simulated insulin output. 
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should be noted that the plasma glucose has returned to its basal level 
within approximately 35 minutes (Fig. 25), which is considerably quicker 
than for the cow or man. Therefore, one may accept these values for 
the "coefficients of regulation" as being representative for the pigs' 
response to an intravenous glucose tolerance test; keeping in mind the 
experimental conditions and age group of the animals. 
This current model was used to depict the overall response of the 
blood glucose regulatory system. It would be feasible to describe 
and simulate additional specific responses of this system provided one 
had sufficient knowledge of the detailed kinetics of basic processes 
involved, e.g. glucose metabolism in each body organ, active transport 
across each cell surface, effect of insulin on glucose metabolism and 
transport, effect of growth hormone, epinephrine, Cortisol, and other 
metabolic factors. Since this detailed information is not available, 
one must lump a large number of parameters into a smaller number, which 
hopefully characterizes the swine glucose regulatory system to a given 
glucose stimulus. The use of peripheral plasma samples to determine 




A requirement of calcium ion for normal insulin secretion during 
an intravenous glucose tolerance test has been demonstrated vivo. 
In the normocalcemic state plasma concentrations of IRI usually in­
creased '4— to 5-fold in dairy cows and pigs during the intravenous glu­
cose tolerance test. However, plasma concentrations of IRI usually in­
creased 1.5-fold in the spontaneous (cows) or induced hypocalcemic (pigs) 
state. In most cases intravenous infusions of calcium borogluconate to 
correct hypocalcemia resulted in an immediate rise in plasma concentra­
tions of IRI during the intravenous glucose tolerance test or naturally 
occurring hyperglycemia often associated with postparturient paresis in 
the dairy cow. 
The significance of relative hypoinsulinemia and naturally occur­
ring hyperglycemia during severe postparturient hypocalcemia (post-
parturient paresis) has not been ascertained. The occurrence of de­
layed insulin secretion to a glycemic stimulus after correction of the 
hypocalcemia was similar to that observed in the mild diabetic. While 
this is indicative of an abnormal cellular response, the exact mechanism 
involved is unknown. 
The regulatory coefficients established for the mathematical model 
and analog simulation of glucose-insulin relationship during the tran­
sient state fit this study quite well. Further testing by analog simu­
lation and physiologic experiments based on simulation data would either 
verify or improve on the estimations of the regulatory coefficients. In 
addition, an expanded mathematical model may be needed to be of signifi­
cant value to basic research in studying the glucose-insulin relationship. 
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